2014 annual financial data
Ernexa Therapeutics 2014 Operating margin
Direct answer
Operating margin was -18.21%.
Operating income was -4,742,000 USD and net income was -5,030,000 USD.
Operating cash flow was -6,385,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,046,000 USD
- Operating income
- -4,742,000 USD
- Net income
- -5,030,000 USD
- Operating cash flow
- -6,385,000 USD